Literature DB >> 11853712

Xenotransplantation of retinal pigment epithelial cells into RCS rats.

Salvatore Grisanti1, Peter Szurman, Jens Jordan, Norbert Kociok, Karl Ulrich Bartz-Schmidt, Klaus Heimann.   

Abstract

PURPOSE: Successful engraftment of retinal pigment epithelial cells (RPE) to treat RPE-related retinopathy will depend, at least in part, on controlling the immune response. In order to understand this process we evaluated the fate of RPE xenografts in the subretinal space, anterior chamber, and subcutis of nonimmunosuppressed Royal College of Surgeons rats.
METHODS: Freshly isolated adult porcine RPE cells were used as xenografts and implanted when recipients were 17 to 21 days old. The extent of photoreceptor rescue by subretinal transplants was determined by counting the maximum layers of surviving photoreceptor nuclei in histologic sections. Cellular immune response was evaluated by immunohistochemistry.
RESULTS: Compared to non- or sham-injected eyes, subretinal xenografts in RPE-transplanted eyes were able to induce a dramatic rescue effect (P <.01). However, the effect was not absolute and photoreceptor cell degeneration was only delayed. Xenografts both in the anterior chamber and in the subcutaneous tissue led to an inflammatory cellular infiltration.
CONCLUSION: RPE xenografts in subcutaneous space and in the anterior chamber are rejected by a delayed but vigorous inflammatory cell infiltration. Subretinal RPE xenografts are protected from a strong cellular rejection, but seem to undergo a slow functional deterioration, reflected by a decline in their capability to rescue adjacent photoreceptors.

Entities:  

Mesh:

Year:  2002        PMID: 11853712     DOI: 10.1016/s0021-5155(01)00464-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  12 in total

1.  A new immunodeficient retinal dystrophic rat model for transplantation studies using human-derived cells.

Authors:  Biju B Thomas; Danhong Zhu; Tai-Chi Lin; Young Chang Kim; Magdalene J Seiler; Juan Carlos Martinez-Camarillo; Bin Lin; Yousuf Shad; David R Hinton; Mark S Humayun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-13       Impact factor: 3.117

2.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

3.  Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer.

Authors:  Bruno Diniz; Padmaja Thomas; Biju Thomas; Ramiro Ribeiro; Yuntao Hu; Rodrigo Brant; Ashish Ahuja; Danhong Zhu; Laura Liu; Michael Koss; Mauricio Maia; Gerald Chader; David R Hinton; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-26       Impact factor: 4.799

4.  Early Subretinal Allograft Rejection Is Characterized by Innate Immune Activity.

Authors:  Kevin P Kennelly; Toby M Holmes; Deborah M Wallace; Cliona O'Farrelly; David J Keegan
Journal:  Cell Transplant       Date:  2017-01-20       Impact factor: 4.064

5.  Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.

Authors:  Yao Li; Yi-Ting Tsai; Chun-Wei Hsu; Deniz Erol; Jin Yang; Wen-Hsuan Wu; Richard J Davis; Dieter Egli; Stephen H Tsang
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

6.  Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.

Authors:  Amanda-Jayne Carr; Anthony A Vugler; Sherry T Hikita; Jean M Lawrence; Carlos Gias; Li Li Chen; David E Buchholz; Ahmad Ahmado; Ma'ayan Semo; Matthew J K Smart; Shazeen Hasan; Lyndon da Cruz; Lincoln V Johnson; Dennis O Clegg; Pete J Coffey
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

Review 7.  Immunologic Rejection of Transplanted Retinal Pigmented Epithelium: Mechanisms and Strategies for Prevention.

Authors:  Carson C Petrash; Alan G Palestine; M Valeria Canto-Soler
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

8.  Regenerative therapy for retinal disorders.

Authors:  Narsis Daftarian; Sahar Kiani; Azadeh Zahabi
Journal:  J Ophthalmic Vis Res       Date:  2010-10

9.  Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration.

Authors:  Manjit S Mehat; Venki Sundaram; Caterina Ripamonti; Anthony G Robson; Alexander J Smith; Shyamanga Borooah; Martha Robinson; Adam N Rosenthal; William Innes; Richard G Weleber; Richard W J Lee; Michael Crossland; Gary S Rubin; Baljean Dhillon; David H W Steel; Eddy Anglade; Robert P Lanza; Robin R Ali; Michel Michaelides; James W B Bainbridge
Journal:  Ophthalmology       Date:  2018-06-05       Impact factor: 12.079

10.  Long-Term Efficacy of GMP Grade Xeno-Free hESC-Derived RPE Cells Following Transplantation.

Authors:  Trevor J McGill; Osnat Bohana-Kashtan; Jonathan W Stoddard; Michael D Andrews; Neelay Pandit; Lior R Rosenberg-Belmaker; Ofer Wiser; Limor Matzrafi; Eyal Banin; Benjamin Reubinoff; Nir Netzer; Charles Irving
Journal:  Transl Vis Sci Technol       Date:  2017-06-14       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.